Related references
Note: Only part of the references are listed.A Randomized Placebo-Controlled Clinical Trial to Evaluate the Medium-Term Effects of Oat Fibers on Human Health: The Beta-Glucan Effects on Lipid Profile, Glycemia and inTestinal Health (BELT) Study
Arrigo F. G. Cicero et al.
NUTRIENTS (2020)
Cereal B-Glucans: The Impact of Processing and How It Affects Physiological Responses
Muriel Henrion et al.
NUTRIENTS (2019)
Statins: pros and cons
Iago Pinal-Fernandez et al.
MEDICINA CLINICA (2017)
Cholesterol-lowering properties of oat β-glucan and the promotion of cardiovascular health: did Health Canada make the right call?
Ifeanyi D. Nwachukwu et al.
APPLIED PHYSIOLOGY NUTRITION AND METABOLISM (2015)
Cholesterol-lowering effects of oat β-glucan: a meta-analysis of randomized controlled trials
Anne Whitehead et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2014)
A comparison of non-HDL and LDL cholesterol goal attainment in a large, multinational patient population: The Lipid Treatment Assessment Project 2
Raul D. Santos et al.
ATHEROSCLEROSIS (2012)
Scientific Opinion on the substantiation of health claims related to beta-glucans from oats and barley and maintenance of normal blood LDL-cholesterol concentrations (ID 1236, 1299), increase in satiety leading to a reduction in energy intake (ID 851, 852), reduction of post-prandial glycaemic responses (ID 821, 824), and digestive function (ID 850) pursuant to Article 13(1) of Regulation (EC) No 1924/2006 EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
Carlo Agostoni et al.
EFSA JOURNAL (2011)
Physicochemical properties of oat β-glucan influence its ability to reduce serum LDL cholesterol in humans: a randomized clinical trial
Thomas M. S. Wolever et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2010)
The effects of diets enriched in beta-glucans on blood lipoprotein concentrations
Jiezhong Chen et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2009)
Statins in atherosclerosis: Lipid-lowering agents with antioxidant capabilities
RS Rosenson
ATHEROSCLEROSIS (2004)
Share Paper
